Physician profile
Eric L Wallace
NPI 1568658243
$4,155.80
in general payments reported to CMS, 2019-2025
19 companies · $341 in 2025
The $341 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $1,390 · 2021: $155 · 2022: $661 · 2023: $420 · 2024: $697 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,456.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,415.42 | 2019-2020 | |
| Boston Scientific Corporation | $798.59 | 2019-2025 | Watchman Flx, General - Vascular Intervention, Mylux Patient Kit With Mobile Device |
| Abbott Laboratories | $645.76 | 2019-2025 | Mitraclip, Amplatzer Amulet |
| Medtronic, INC. | $404.93 | 2022-2025 | Corevalve Evolut R |
| Chiesi USA, INC. | $355.28 | 2019-2025 | Elfabrio |
| Janssen Pharmaceuticals, INC | $161.79 | 2019-2024 | Xarelto |
| Edwards Lifesciences Corporation | $107.29 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Cardiva Medical, INC. | $56.19 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Savvywire |
| Intuitive Surgical, INC. | $50.95 | 2019 | |
| Novo Nordisk INC | $44.36 | 2023 | |
| Abiomed | $41.22 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $23.62 | 2022 | |
| Shockwave Medical, INC | $18.53 | 2021 | |
| Amgen INC. | $17.50 | 2023 | Repatha |
| Merck Sharp & Dohme LLC | $14.37 | 2020 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.